Reed David E, Lehinger Elizabeth, Cobos Briana, Vail Kenneth E, Nabity Paul S, Helm Peter J, Galgali Madhwa S, McGeary Donald D
Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Care, Seattle, WA, United States.
Department of Psychiatry and Behavioral Sciences, Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Front Psychol. 2021 Apr 28;12:643869. doi: 10.3389/fpsyg.2021.643869. eCollection 2021.
The novel coronavirus (2019; CV-19) is linked to increases in emotional distress and may be particularly problematic for those with pre-existing mental and physical conditions, such as chronic pain and posttraumatic stress disorder (PTSD). However, little empirical research has been published on resilience factors in these individuals. The present study aims to examine authenticity as a resilience factor among those with chronic pain and/or PTSD.
Prior to the national response to the pandemic (January 10-24, 2020), participants were screened for pain-related disability (Oswestry Disability Index; ODI) and PTSD symptoms (Posttraumatic Checklist for DSM-5; PCL-5), and on the basis of those responses were categorized into one of four groups: healthy, chronic pain only, PTSD only, or comorbid chronic pain and PTSD. During the CV-19 pandemic (May 5-May 13, 2020), participants responded again to the ODI and PCL-5, in addition to the Wood Authenticity Scale, Brief Pain Inventory, and items related to the CV-19 pandemic.
A total of 110 participants (54.55% women), aged 42.19 ( = 13.16), completed the survey during the pandemic. The comorbid group endorsed higher levels of CV-19 Threat and Impact compared to all other groups. Authenticity moderated this relationship relevant to CV-19 Threat among those in the chronic pain only group, and not in any other group.
The comorbid group endorsed higher levels of CV-19 Threat and Impact compared to all other groups. Importantly, greater authenticity was associated with less CV-19 Threat in the chronic pain only group, and not in any other group. The present study also highlights the importance of engaging authentically for those with chronic pain during the pandemic.
新型冠状病毒（2019；CV - 19）与情绪困扰的增加有关，对于那些已有精神和身体疾病的人，如慢性疼痛和创伤后应激障碍（PTSD）患者，可能尤其成问题。然而，关于这些个体复原力因素的实证研究很少发表。本研究旨在检验真实性作为慢性疼痛和/或PTSD患者复原力因素的情况。
在国家对疫情做出反应之前（2020年1月10日至24日），对参与者进行疼痛相关残疾筛查（奥斯维斯特里残疾指数；ODI）和PTSD症状筛查（DSM - 5创伤后检查表；PCL - 5），并根据这些反应将他们分为四组之一：健康组、仅患有慢性疼痛组、仅患有PTSD组或慢性疼痛与PTSD共病组。在CV - 19大流行期间（2020年5月5日至13日），参与者除了再次对ODI和PCL - 5做出反应外，还对伍德真实性量表、简明疼痛量表以及与CV - 19大流行相关的项目做出反应。
共有110名参与者（54.55%为女性），年龄42.19（= 13.16），在大流行期间完成了调查。与所有其他组相比，共病组认可的CV - 19威胁和影响水平更高。真实性调节了仅患有慢性疼痛组中与CV - 19威胁相关的这种关系，而在其他任何组中均未调节。
与所有其他组相比，共病组认可的CV - 19威胁和影响水平更高。重要的是，在仅患有慢性疼痛组中，更高的真实性与更低的CV - 19威胁相关，而在其他任何组中均无此关联。本研究还强调了在大流行期间真实投入对慢性疼痛患者的重要性。
